Physician

George H Domb, M.D.

According to 2025 Medicare claims, George Domb, M.D. (NPI: 1962426833) practices otolaryngology in the Redding, CA market, with the plurality of this provider's patient population coming from Shasta, CA. This provider's primary affiliated billing organization is SHASTA ENT SPECIALISTS (NPI: 1801817929; TIN: 75-3080537) and primary practice location at 96001-2531.

Domb's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 594 traditional Medicare patients, billed 4,930 HCPCS/CPT codes, and received $639,533 in Medicare payments. The top billing code was 31231 (Diagnostic exam of nasal passages using an endoscope). Part D data shows 2,129 prescription claims across 405 beneficiaries totaling $205,586 in drug costs, led by Dupixent Pen (Dupilumab). DME data shows 402 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $137,005 to $205,586. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $1,744 to $10,111.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	748	5,131	$605,713
2016	709	5,401	$625,378
2017	700	5,426	$702,042
2018	665	5,729	$842,738
2019	700	5,901	$929,893
2020	609	4,399	$637,498
2021	652	4,904	$656,422
2022	698	5,020	$617,731
2023	671	5,329	$697,581
2024	594	4,930	$639,533

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	375	1,819	$137,005
2016	409	2,311	$107,596
2017	420	2,342	$102,026
2018	419	2,669	$125,894
2019	419	2,387	$130,904
2020	383	1,931	$151,245
2021	358	1,882	$216,541
2022	398	2,026	$197,110
2023	416	2,136	$173,324
2024	405	2,129	$205,586

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	44	$4,320
2016	N/R	131	$52,791
2017	N/R	193	$107,811
2018	N/R	190	$125,796
2019	N/R	165	$80,064
2020	N/R	391	$269,104
2021	N/R	337	$305,074
2022	N/R	241	$246,947
2023	N/R	294	$249,872
2024	23	402	$535,780

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
31231	Diagnostic exam of nasal passages using an endoscope	434	1,154	$129
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	258	440	$127
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	436	941	$90
69210	Removal of impacted ear wax	195	307	$24
92504	Exam of ear using a microscope	200	326	$20

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Pen	Dupilumab	16	504	$67,412
Dupixent Syringe	Dupilumab	15	420	$56,806
Azelastine Hcl	Azelastine Hcl	399	18,610	$15,721
Gamastan	Immune Globul G (Igg)/Glycine	72	2,674	$13,163
Ipratropium Bromide	Ipratropium Bromide	206	9,141	$8,537

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	11	88	$358,901
J1558	Injection, immune globulin (xembify), 100 mg	N	N/R	13	$50,089
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	N	N/R	15	$42,482
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	N	N/R	13	$40,187
J7639	Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram	N	N/R	11	$34,165

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for George H. Domb, M.D.?

Tedicare shows public-source Medicare data for George H. Domb, M.D. (NPI 1962426833), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does George H. Domb, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to George H. Domb, M.D.?

George H. Domb, M.D. is linked to SHASTA ENT SPECIALISTS (billing NPI 1801817929) in the available physician profile data.

Does George H. Domb, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.